Zhen Teng Liu

Chief Executive Officer at SHANDONG LUOXIN PHARMACY GROUP CO LTD

Net worth: 3 M $ as of 31/05/2024

38 year

Health Technology

Consumer Services

Profile

Zhen Teng Liu is currently the Chairman & General Manager at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
and Luoxin Pharmaceuticals Group Stock Co., Ltd.
He started his current positions in 2013 and 2020 respectively.
In terms of education, Mr. Liu holds an MBA from The University of New South Wales and an undergraduate degree from Macquarie University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ZHEJIANG DOYIN PUMP INDUSTRY CO. LTD. 0.96%	21/07/2023	4,689,648 ( 0.96% )	3 M $	31/05/2024

Zhen Teng Liu active positions

Companies	Position	Start
SHANDONG LUOXIN PHARMACY GROUP CO LTD	Chief Executive Officer	31/01/2023
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.	Chief Executive Officer	23/04/2023

All active positions of Zhen Teng Liu

Training of Zhen Teng Liu

Macquarie University	Undergraduate Degree
The University of New South Wales	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zhen Teng Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.	Health Technology

Private companies	1
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China.	Health Technology